英语的翻译：
Dr. Virginia School of Medicine pharmacology, post-doctoral at Harvard Medical School, graduated from Peking University and Fudan University School of Public Health, School of Public Health.
Has served in the Chinese Ministry of Health by the identification of biological products Drugs, assistant researcher at the Stanford University School of Medicine, the United States Chiron (Kangren), a senior researcher at the pharmaceutical company Bayer in the Asia-Pacific director of technology and development.
Established in Shanghai Kida Gene Technology Co., Ltd., the managing director; development of the advanced international level of gene diagnosis technology and products, including the Shanghai Magnolia talent bonus eight Shanghai Municipal Government Development Fund, and four of molecular biology Technology patents.
Dr. Cao Bo founder of the Wuxi bridge biomedical Technology Limited, a leader of Wuxi venture personnel returning from overseas study plan (that is, Wuxi, "530" plan) is assigned to Class A, is the incubator of high technology provinces and cities of one of the main highlights. Its project "hand-held electronic sensor chemical analysis of immune system", characterized by a combination of the most rapid test reagents and electrochemical sensing electrodes specimens of the design, a plug-and-play portable memory card interface detection, in notebook computers (NB) or personal digital assistant (PDA) can be executed on the test, simple, only three minutes to complete the test. This product is based on simplicity, convenience, rapid and time-saving, the provincial capital of the properties, together with the biotechnology industry recognized by the antibody specific products led to the high stability, promoting the value highly.
Dr. Virginia School of Medicine pharmacology, post-doctoral at Harvard Medical School, graduated from Peking University and Fudan University School of Public Health, School of Public Health.
Has served in the Chinese Ministry of Health by the identification of biological products Drugs, assistant researcher at the Stanford University School of Medicine, the United States Chiron (Kangren), a senior researcher at the pharmaceutical company Bayer in the Asia-Pacific director of technology and development.
Established in Shanghai Kida Gene Technology Co., Ltd., the managing director; development of the advanced international level of gene diagnosis technology and products, including the Shanghai Magnolia talent bonus eight Shanghai Municipal Government Development Fund, and four of molecular biology Technology patents.
Dr. Cao Bo founder of the Wuxi bridge biomedical Technology Limited, a leader of Wuxi venture personnel returning from overseas study plan (that is, Wuxi, "530" plan) is assigned to Class A, is the incubator of high technology provinces and cities of one of the main highlights. Its project "hand-held electronic sensor chemical analysis of immune system", characterized by a combination of the most rapid test reagents and electrochemical sensing electrodes specimens of the design, a plug-and-play portable memory card interface detection, in notebook computers (NB) or personal digital assistant (PDA) can be executed on the test, simple, only three minutes to complete the test. This product is based on simplicity, convenience, rapid and time-saving, the provincial capital of the properties, together with the biotechnology industry recognized by the antibody specific products led to the high stability, promoting the value highly.
Dr. Virginia School of Medicine pharmacology, post-doctoral at Harvard Medical School, graduated from Peking University and Fudan University School of Public Health, School of Public Health.
Has served in the Chinese Ministry of Health by the identification of biological products Drugs, assistant researcher at the Stanford University School of Medicine, the United States Chiron (Kangren), a senior researcher at the pharmaceutical company Bayer in the Asia-Pacific director of technology and development.
Established in Shanghai Kida Gene Technology Co., Ltd., the managing director; development of the advanced international level of gene diagnosis technology and products, including the Shanghai Magnolia talent bonus eight Shanghai Municipal Government Development Fund, and four of molecular biology Technology patents.
Dr. Cao Bo founder of the Wuxi bridge biomedical Technology Limited, a leader of Wuxi venture personnel returning from overseas study plan (that is, Wuxi, "530" plan) is assigned to Class A, is the incubator of high technology provinces and cities of one of the main highlights. Its project "hand-held electronic sensor chemical analysis of immune system", characterized by a combination of the most rapid test reagents and electrochemical sensing electrodes specimens of the design, a plug-and-play portable memory card interface detection, in notebook computers (NB) or personal digital assistant (PDA) can be executed on the test, simple, only three minutes to complete the test. This product is based on simplicity, convenience, rapid and time-saving, the provincial capital of the properties, together with the biotechnology industry recognized by the antibody specific products led to the high stability, promoting the value highly.
参考
内容全部来源于网络收集，如有侵权，请联系网站删除：QQ：24596024